ArticleJournal of rehabilitation medicine2026
Suprapubic catheter insertion in people with multiple sclerosis: long-term complications and survival in a retrospective cohort study.
Article in Journal of rehabilitation medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate complications and survival following radiologically guided suprapubic catheter insertion in people with multiple sclerosis.
designRetrospective cohort study. SUBJECTS/PATIENTS: All patients with multiple sclerosis who underwent radiologically guided suprapubic catheter insertion at a tertiary regional multiple sclerosis centre in the United Kingdom between 2014 and 2020.
methodsClinical and demographic data were obtained from medical records. Immediate complications occurring within 30 days and delayed complications occurring after 30 days were recorded. Kaplan-Meier and Cox regression analyses were performed to assess survival predictors.
resultsFifty-five patients underwent suprapubic catheter insertion. At the time of insertion, mean age was 62 years (standard deviation 11) and median duration of multiple sclerosis was 17.5 years (1st quartile = 12.0; 3rd quartile = 25.8). Immediate and delayed complication rates were 16% (9) and 27% (15), respectively. Five-year survival was 73%. Older age, higher disability scores, longer disease duration, and discharge to residential care were associated with poorer survival. Complications, sex, and mobility status were not associated with mortality.
conclusionRadiologically guided suprapubic catheter insertion was associated with moderate complication rates and long-term survival in people with multiple sclerosis. These findings may allow better understanding of the potential complications of suprapubic catheterization in advanced multiple sclerosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.